KYNTRA Leadership Thursday, October 1, 2026 +0.30 Positive

Kyntra Bio Appoints Director Singer

Kyntra Bio appointed Andrew Singer to its board as independent director and Audit Committee member; simultaneously, Maykin Ho stepped down following eight years of service. This leadership change aligns with the company's expansion in rare disease and oncology.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed